Marksans Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Marksans Pharma Ltd. on BSE

Load latest

Marksans Pharma Ltd.

11 Oct 2023

169.46

3.18%

Company Update

MARKSANS PHARMA LTD. - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed certificate under regulation 74(5) of SEBI Depositories regulation for quarter ended September 30, 2023 received from Bigshare Services Private Limited(RTA).

pdf

Marksans Pharma Ltd.

04 Oct 2023

169.46

3.18%

Corp. Note

MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

We have received one request from a shareholder for issue of duplicate share certificate in lieu of lost/misplaced original share certificate

pdf

Marksans Pharma Ltd.

03 Oct 2023

169.46

3.18%

Company Update

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Final approval from US FDA for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium delayed-release capsule USP, 20 mg (OTC).

pdf

Marksans Pharma Ltd.

29 Sep 2023

169.46

3.18%

SAST

MARKSANS PHARMA LTD. - 524404 - Closure of Trading Window

BSE India

In terms of Company''s code of conduct and SEBI (PIT) regulations, the trading window will remain closed from Sunday, 1st October, 2023 til 48hrs after the declaration of financial results for quarter ended September 30, 2023.

pdf

Marksans Pharma Ltd.

31 Aug 2023

169.46

3.18%

Corp. Note

MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

We have received one request from shareholder for issue of duplicate share certificate in lieu of lost/misplaced share certificate. Our RTA has received the completed documents for issuing duplicate share certificate on August 30, 2023

pdf

Marksans Pharma Ltd.

30 Aug 2023

169.46

3.18%

Company Update

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of …

BSE India

Pursuant to regulation 30 of SEBI (LODR), kindly note that the members of the Company at the AGM held on Monday August 28, 2023 have inter alia approved the amendment to the Articles of Association of the Company.

pdf

Marksans Pharma Ltd.

29 Aug 2023

169.46

3.18%

AGM

MARKSANS PHARMA LTD. - 524404 - Voting Results Along With Scrutinizers Report

BSE India

Pursuant to Regulation 44(3) of LODR, Results of the voting through remote evoting and evoting during AGM held on 28th August, 2023 through video conferencing along with consolidated Scrutinizers Reports.

pdf

Marksans Pharma Ltd.

28 Aug 2023

169.46

3.18%

AGM

MARKSANS PHARMA LTD. - 524404 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to regulation 30 of SEBI (LODR) regulations, 2015, kindly find enclosed herewith proceedings of 31st AGM of Marksans Pharma Limited

pdf

Marksans Pharma Ltd.

28 Aug 2023

169.46

3.18%

Company Update

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

This is to inform you that the officials of the Company will be participating in the investor/analyst conference on August 28, 2023.

pdf

Marksans Pharma Ltd.

22 Aug 2023

169.46

3.18%

Company Update

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

In terms of company''s code of conduct read with schedule B & regulation 9 of SEBI (PIT) regulations, we hereby submit a report in respect of violation of insider trading code of the Company as per the format prescribed by SEBI.

pdf

Is Marksans Pharma Ltd. worth buying?

1426 Votes:

Buy 80.5%

Sell 10.17%

Hold 9.33%

New 52W Low in past week

High volume today

Marksans Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Marksans Pharma Ltd. on BSE